Teva Pharmaceutical Industries Ltd

Ownership Transactions Reported by 33 Insiders

Symbol
TEVA on NYSE, TEVJF on OTC
Location
Teva Pharmaceutical Industries Limited, 124 Dvora Hanevi'a St., Tel Aviv, Israel

Insiders trading volume in the past year

Teva Pharmaceutical Industries Ltd executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Amir Elstein Director $34.9 M Jun 15, 2024
Roberto Mignone Director $18.3 M -$8.84 M -32.5% Jun 18, 2024
Kare Schultz President and CEO, Director $15 M Nov 1, 2022
Sol J. Barer Director $6.81 M Jun 15, 2024
Mark Sabag EVP, International Markets $5.17 M -$1.35 M -20.7% Mar 5, 2024
Eliyahu Sharon Kalif EVP, Chief Financial Officer $2.75 M -$1.39 M -33.6% Mar 5, 2024
Eric Drape Executive VP Global Operations $1.97 M -$2.39 M -54.8% Mar 5, 2024
Gerald M. Lieberman Director $1.77 M Jun 15, 2024
Rosemary A. Crane Director $1.73 M Jun 15, 2024
Richard D. Francis President and CEO $1.64 M -$1.39 M -45.9% Mar 3, 2024
Sven Dethlefs EVP, North America Commercial $1.61 M Mar 6, 2023
Perry Nisen Director $1.59 M Jun 15, 2024
Ronit Satchi-Fainaro Director $1.47 M Jun 15, 2024
Richard Daniell Exec. VP, European Commercial $1.34 M -$2.2 M -62.2% Mar 5, 2024
Dov Bergwerk Acting Chief Legal Officer $1.27 M Feb 28, 2024
Janet S. Vergis Director $1.07 M Jun 15, 2024
Tal Zvi Zaks Director $818 K Jun 15, 2024
Jean Michel Halfon Director $620 K Aug 4, 2022
Nechemia Jacob Peres Director $572 K Aug 4, 2022
Eli Shani EVP,Global Marketing&Portfolio $528 K Mar 3, 2023
Galia Inbar EVP, Chief Human Resources Officer and Corporate Affairs $448 K Mar 3, 2023
Eric Hughes Executive Vice President, Global R&D and Chief Medical Officer $225 K -$545 K -70.8% Mar 3, 2024
Amir Weiss Chief Accounting Officer $86.2 K -$883 K -91.1% May 15, 2024
David M. Stark Exec. VP Chief Legal Officer $29 K Mar 6, 2023
Hafrun Fridriksdottir Executive VP, Global R&D $13.5 K May 17, 2022
Vikki L. Conway Acting Head of Global Human Resources $0 -$339 K -100% May 13, 2024
Angus Grant EVP, Business Development Mar 4, 2024
Andrew Weil Chief Accounting Officer Nov 2, 2021
Christine Fox EVP, Head of U.S. Commercial Mar 4, 2024
David R. McAvoy EVP, Chief Legal Officer Mar 4, 2024
Matthew Shields EVP, Global Operations Jun 3, 2024
Varda Shalev Director Jun 6, 2024
Abbas Hussain Director Jun 14, 2021

Recent Insider Transactions by Companies or Individuals for Teva Pharmaceutical Industries Ltd

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership